Research results underscore the importance of understanding the characteristics of Legionnaires’ disease and the need for early diagnosis.
Children with GII.4 type norovirus had more severe symptoms and required more medical care.
Four medical societies have come together to publish an updated consensus guideline on dosing and monitoring vancomycin for the treatment of serious MRSA infections.
In immunocompromised adults, community-acquired pneumonia should be treated by a multidisciplinary team of physicians.
Treatment with daptomycin for bacteremia caused by methicillin-resistant Staphylococcus aureus complicated by septic pulmonary emboli was found to have a success rate comparable to daptomycin-ceftaroline fosamil.
According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic reactions, and microvascular obstruction, including pulmonary embolism.”
Upon starting methotrexate treatment, LDH and albumin levels may be signals for AKIs in patients with hematologic malignancies.
A retrospective study of CMV-seropositive adults receiving allogeneic HCT and CMV-seronegative HLA-matched sibling donors found that vancomycin exposure before HCT increased the risk for CMV reactivation.
A post hoc analysis was conducted to assess the efficacy of bezlotoxumab in a subgroup of participants from the MODIFY I and II trials.
An interactive, in-person barrier identification and mitigation tool can ensure safe administration of home-based outpatient parenteral antimicrobial therapy.
Merck announced results from the phase 3 RESTORE-IMI 2 trial of imipenem/relebactam/cilastatin (Recarbrio™) for the treatment of adults with hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP).
Veterans Affairs hospitals adopted more infection prevention practices than non-VA hospitals.
Healthcare workers were more likely to partake in hand-hygiene protocols after contaminating tasks vs critical tasks and before such tasks.
Rates of hospitalizations for serious bacterial infections among people with substance use disease are increasing, especially in younger populations.
Eradication of prosthetic hip and knee joint infections is challenging, with failure rates >20% even in the setting of complete prosthesis removal.
Infection prevention programs targeting low-income groups undergoing colectomy may be important in reducing surgical site infections.
Recent reports present updated summaries of common pathogens and antimicrobial resistance patterns among health care-associated infections.
The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.
There is a need to improve infectious risk mitigation in adults with diabetes because they are hospitalized for infections between 2.6 and 15.7 times as often as adults without diabetes, depending on the type of infection.
Among individuals with acute myelogenous leukemia (AML), carbapenem-nonsusceptible gram-negative bacteremia (GNB) is associated with worse outcomes than carbapenem-susceptible GNB.